Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,076,000 | -68,000 | 17,941,000 | 14,421,000 | 9,963,000 |
| Depreciation Amortization | 3,814,000 | 1,880,000 | 6,970,000 | 5,198,000 | 3,513,000 |
| Income taxes - deferred | -2,342,000 | -1,543,000 | -1,663,000 | -2,488,000 | -2,349,000 |
| Accounts receivable | -599,000 | -53,000 | -1,307,000 | -1,605,000 | -1,389,000 |
| Other Working Capital | -138,000 | 2,264,000 | -4,028,000 | -2,786,000 | -2,745,000 |
| Other Operating Activity | 1,628,000 | 777,000 | 3,281,000 | 3,104,000 | 2,567,000 |
| Operating Cash Flow | $7,439,000 | $3,257,000 | $21,194,000 | $15,844,000 | $9,560,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,871,000 | -823,000 | -3,466,000 | -2,100,000 | -1,156,000 |
| Net Acquisitions | N/A | N/A | -17,652,000 | -522,000 | -523,000 |
| Purchase Of Investment | -9,688,000 | -3,774,000 | -32,384,000 | -31,163,000 | -22,048,000 |
| Sale Of Investment | 11,877,000 | 7,766,000 | 41,609,000 | 26,324,000 | 17,634,000 |
| Other Investing Activity | -779,000 | 146,000 | -478,000 | -513,000 | -180,000 |
| Investing Cash Flow | $-461,000 | $3,315,000 | $-12,371,000 | $-7,974,000 | $-6,273,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 12,221,000 | 11,094,000 | 16,134,000 | 7,099,000 | 4,371,000 |
| Debt Issued | 7,674,000 | 7,674,000 | 2,000 | 1,000 | 2,000 |
| Debt Repayment | -501,000 | -500,000 | -2,134,000 | -2,133,000 | -2,132,000 |
| Common Stock Issued | 4,495,000 | -11,000 | 1,329,000 | 907,000 | 820,000 |
| Common Stock Repurchased | -3,918,000 | -3,537,000 | -6,035,000 | -4,715,000 | -2,550,000 |
| Dividend Paid | -6,034,000 | -2,942,000 | -11,682,000 | -8,728,000 | -5,758,000 |
| Other Financing Activity | -13,790,000 | -5,640,000 | -6,485,000 | -3,002,000 | -1,399,000 |
| Financing Cash Flow | $147,000 | $6,138,000 | $-8,871,000 | $-10,571,000 | $-6,646,000 |
| Exchange Rate Effect | -69,000 | 28,000 | -312,000 | -431,000 | -145,000 |
| Beginning Cash Position | 14,127,000 | 14,127,000 | 14,487,000 | 14,487,000 | 14,487,000 |
| End Cash Position | 21,183,000 | 26,865,000 | 14,127,000 | 11,355,000 | 10,983,000 |
| Net Cash Flow | $7,056,000 | $12,738,000 | $-360,000 | $-3,132,000 | $-3,504,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,439,000 | 3,257,000 | 21,194,000 | 15,844,000 | 9,560,000 |
| Capital Expenditure | -1,987,000 | -863,000 | -4,009,000 | -2,422,000 | -1,470,000 |
| Free Cash Flow | 5,452,000 | 2,394,000 | 17,185,000 | 13,422,000 | 8,090,000 |